Toshiba America Medical Systems has received approval from the US Food and Drug Administration (FDA) for its new detector and CT software enhancements, which are designed for Aquilion One Family of CT systems.
The new enhancements that secured approval include AIDR 3D, which is an advanced iterative noise reduction algorithm, and PURE ViSION CT Detector that can provide 40% improved light output for better use of X-ray photons.
Toshiba CT business unit senior director Satrajit Misra said: "We understand quality measures are directly linked to patient safety and satisfaction, and at Toshiba, we continue to develop technology that helps our customers meet their goals.
"Toshiba offers a fully comprehensive and responsive safety program with 360 degrees of coverage, guidance and expertise that go beyond radiation dose and extend to other areas of patient and staff safety."
Other enhancements include SUREkV that provides automated kV selection based on patient size and organ effective modulation, which offers safer exams for both patients and providers by limiting dose to radiosensitive organs and during helical scanning and CT fluoroscopy procedures.
In addition, the company is offering enhanced contrast management that improves workflow and safety by standardizing contrast protocols and automatically tracking volume of contrast used during an exam and power safe mode that decreases energy consumption when CT system is not in use.
Image: Toshiba has obtained FDA approval for new detector and CT software enhancements of Aquilion One Family of CT systems. Photo: courtesy of Stuart Miles/ FreeDigitalPhotos.net.